{"id":1195,"date":"2026-10-04T21:18:16","date_gmt":"2026-10-04T21:18:16","guid":{"rendered":"https:\/\/muhammetozgehan.com\/traitements-medicaux-solutions-pharmacologiques-et-topiques\/"},"modified":"2026-10-08T21:33:50","modified_gmt":"2026-10-08T21:33:50","slug":"traitements-medicaux-solutions-pharmacologiques-et-topiques","status":"publish","type":"page","link":"https:\/\/muhammetozgehan.com\/fr\/traitements-medicaux-solutions-pharmacologiques-et-topiques\/","title":{"rendered":"Traitements M\u00e9dicaux (Solutions Pharmacologiques et Topiques)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1195\" class=\"elementor elementor-1195 elementor-368\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f5ea282 e-flex e-con-boxed e-con e-parent\" data-id=\"f5ea282\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-93fab41 elementor-widget elementor-widget-html\" data-id=\"93fab41\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<div class=\"medical-guide-page-wrapper\">\r\n    <!-- Sayfa \u00dcst\u00fc K\u00fcresel Ba\u015fl\u0131k & Logo Alan\u0131 -->\r\n    <div class=\"guide-hero\">\r\n        <div class=\"hero-title-wrapper\">\r\n            <div class=\"hero-logo-box\">\r\n                <img decoding=\"async\" src=\"https:\/\/muhammetozgehan.com\/wp-content\/uploads\/2026\/10\/logo-seffaf.png\" alt=\"Logo du Dr Muhammet \u00d6zgehan\" width=\"32\" height=\"32\" class=\"hero-inline-logo\" title=\"\">\r\n            <\/div>\r\n            <h2>Encyclop\u00e9die M\u00e9dicale Capillaire<\/h2>\r\n        <\/div>\r\n        <p class=\"guide-subtitle\">Pathologies dermatologiques et guides cliniques fond\u00e9s sur des preuves, selon les normes internationales.<\/p>\r\n    <\/div>\r\n\r\n    <!-- Ana Makale Konteyneri -->\r\n    <article class=\"medical-article-card\">\r\n        <div class=\"article-header\">\r\n            <span class=\"article-category\">TRAITEMENTS CAPILLAIRES & APPROCHE M\u00c9DICALE<\/span>\r\n            <h1>Traitements M\u00e9dicaux (Solutions Pharmacologiques et Topiques) \u2013 Guide de Gestion Clinique<\/h1>\r\n            <div class=\"author-meta-box\">\r\n                <p><strong>Pr\u00e9par\u00e9 par :<\/strong> Dr. Muhammet \u00d6zgehan | Association Turque des Maladies des Cheveux et du Cuir Chevelu<\/p>\r\n                <p class=\"compilation-note\"><em>Ce guide a \u00e9t\u00e9 compil\u00e9 par le Dr Muhammet \u00d6zgehan, en s'appuyant sur la litt\u00e9rature trichologique actuelle.<\/em><\/p>\r\n            <\/div>\r\n        <\/div>\r\n\r\n        <!-- Hasta Bilgilendirme B\u00f6l\u00fcm\u00fc -->\r\n        <section class=\"patient-info-box\">\r\n            <h3>\ud83d\udccc Section d'Information Patient : Que signifient les Traitements M\u00e9dicaux ?<\/h3>\r\n            <p>La perte de cheveux ou la diminution de leur qualit\u00e9 ne n\u00e9cessitent pas toujours des interventions chirurgicales comme la greffe de cheveux. Aux stades pr\u00e9coces et interm\u00e9diaires o\u00f9 les follicules pileux n'ont pas encore compl\u00e8tement perdu leur vitalit\u00e9 et sont en cours de miniaturisation (r\u00e9duction), les <strong>traitements m\u00e9dicaux<\/strong> sont les m\u00e9thodes les plus fondamentales pour pr\u00e9server les cheveux et arr\u00eater la chute. <\/p>\r\n            <ul class=\"styled-list\">\r\n                <li><strong>Dans quels cas sont-ils appliqu\u00e9s ? :<\/strong> Ils sont privil\u00e9gi\u00e9s aux stades pr\u00e9coces de la chute de cheveux de type masculin (alop\u00e9cie androg\u00e9n\u00e9tique) ou f\u00e9minin (FPHL), dans les cas d'effluvium t\u00e9log\u00e8ne (chute diffuse) et dans le but d'am\u00e9liorer la qualit\u00e9 des tiges capillaires.<\/li>\r\n                <li><strong>Comment agissent-ils ? :<\/strong> Ils augmentent le flux sanguin capillaire vers les follicules pileux, soutiennent la nutrition des racines et att\u00e9nuent la pression n\u00e9gative des hormones responsables de la chute des cheveux (par exemple, la DHT) sur les follicules.<\/li>\r\n                <li><strong>Quand les r\u00e9sultats sont-ils obtenus ? :<\/strong> En raison de la lenteur du cycle biologique du cheveu, les premi\u00e8res am\u00e9liorations significatives et la r\u00e9duction de la chute dans les traitements m\u00e9dicaux commencent g\u00e9n\u00e9ralement \u00e0 \u00eatre perceptibles entre <strong>3 et 6 mois<\/strong>.<\/li>\r\n            <\/ul>\r\n        <\/section>\r\n\r\n        <!-- 1. G\u00f6rsel: Minoksidil ve Finasterid \/ Dutasterid Mekanizmas\u0131 -->\r\n        <div class=\"medical-illustration-box\">\r\n            <img decoding=\"async\" src=\"https:\/\/muhammetozgehan.com\/wp-content\/uploads\/2026\/10\/dr-muhammet-ozgehan-minoksidil-finasterid-etki-mekanizmasi.png\" alt=\"M\u00e9canismes d&#039;Action du Minoxidil, du Finast\u00e9ride et du Dutast\u00e9ride - Dr. Muhammet \u00d6zgehan\" title=\"\">\r\n            <p class=\"illustration-caption\">Figure 1 : Effet du minoxidil sur l'augmentation de la microcirculation vasculaire et m\u00e9canismes d'action du finast\u00e9ride et du dutast\u00e9ride par blocage de l'enzyme 5-alpha r\u00e9ductase et r\u00e9duction de la DHT.<\/p>\r\n        <\/div>\r\n\r\n        <!-- Hekimler \u0130\u00e7in Klinik K\u0131lavuz (B\u00f6l\u00fcm 1) -->\r\n        <section class=\"doctor-guide-box\">\r\n            <h3>\ud83e\ude7a Guide Clinique & M\u00e9dical pour les M\u00e9decins<\/h3>\r\n            <ul class=\"styled-list doctor-list\">\r\n                <li><strong>\u00c9tiologie et Approche Pharmacologique :<\/strong> Ciblage des facteurs androg\u00e9niques et vasculaires impliqu\u00e9s dans la miniaturisation du follicule pileux. Soutien de la prolif\u00e9ration des cellules folliculaires. <\/li>\r\n                <li><strong>Agents Topiques et Syst\u00e9miques :<\/strong>\r\n                    <ul class=\"sub-list\">\r\n                        <li><em>Minoxidil (2 % et 5 %) :<\/em> Formulations topiques et orales \u00e0 faible dose qui prolongent la phase anag\u00e8ne et augmentent le diam\u00e8tre du cheveu en augmentant la lib\u00e9ration du facteur de croissance endoth\u00e9lial vasculaire (VEGF).<\/li>\r\n                        <li><em>Inhibiteurs de la 5-Alpha R\u00e9ductase :<\/em> Agents syst\u00e9miques (finast\u00e9ride\/dutast\u00e9ride) qui suppriment la conversion de la testost\u00e9rone en dihydrotestost\u00e9rone (DHT) dans les cas de chute de cheveux de type masculin.<\/li>\r\n                    <\/ul>\r\n                <\/li>\r\n            <\/ul>\r\n        <\/section>\r\n\r\n        <!-- 2. G\u00f6rsel: Kad\u0131n Tipi Sa\u00e7 D\u00f6k\u00fclmesinde Antiandrojen Tedavi -->\r\n        <div class=\"medical-illustration-box\" style=\"margin-top: 40px;\">\r\n            <img decoding=\"async\" src=\"https:\/\/muhammetozgehan.com\/wp-content\/uploads\/2026\/10\/dr-muhammet-ozgehan-kadin-tipi-sac-dokulmesi-anti-androjen-tedavi.png\" alt=\"Traitement Antiandrog\u00e8ne dans la Chute de Cheveux de Type F\u00e9minin - Dr. Muhammet \u00d6zgehan\" title=\"\">\r\n            <p class=\"illustration-caption\">Figure 2 : Voies de blocage des r\u00e9cepteurs et de r\u00e9gulation hormonale au niveau folliculaire par des agents antiandrog\u00e8nes tels que la spironolactone et l'ac\u00e9tate de cyprot\u00e9rone dans la chute de cheveux de type f\u00e9minin.<\/p>\r\n        <\/div>\r\n\r\n        <!-- Hekimler \u0130\u00e7in Klinik K\u0131lavuz (B\u00f6l\u00fcm 2) -->\r\n        <section class=\"doctor-guide-box\">\r\n            <ul class=\"styled-list doctor-list\" style=\"margin-top: 0;\">\r\n                <li><strong>Antiandrog\u00e8nes (pour les patientes) :<\/strong> Gestion, chez les patientes pr\u00e9sentant des signes d'hyperandrog\u00e9nie (acn\u00e9, hirsutisme, etc.), d'agents tels que la spironolactone, l'ac\u00e9tate de cyprot\u00e9rone ou le flutamide par blocage des r\u00e9cepteurs aux androg\u00e8nes et suppression des androg\u00e8nes ovariens\/surr\u00e9naliens.<\/li>\r\n                <li><strong>Suivi Clinique et Gestion des Combinaisons :<\/strong> Optimisation des agents pharmacologiques uniques en fonction du profil \u00e9tiologique du patient. Suivi p\u00e9riodique du diam\u00e8tre et de la densit\u00e9 des cheveux par trichoscopie num\u00e9rique. De plus, pour les \u00e9valuations cliniques et chirurgicales, les <a href=\"https:\/\/www.muhammetozgehan.com.tr\" target=\"_blank\" rel=\"noopener\">approches d'expertise et de traitement<\/a> peuvent \u00eatre examin\u00e9es.  <\/li>\r\n            <\/ul>\r\n        <\/section>\r\n\r\n        <!-- Bilimsel Referanslar -->\r\n        <section class=\"scientific-references-box\">\r\n            <h3>R\u00e9f\u00e9rences Scientifiques et Bibliographie<\/h3>\r\n            <ul class=\"ref-list\">\r\n                <li>Gupta AK, Talukder M, Williams G. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. <em>J Dermatolog Treat.<\/em> 2022 Nov;33(7):2946-2962. doi: 10.1080\/09546634.2022.2109567. Epub 2022 Aug 15. PMID: 35920739. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35920739\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a><\/li>\r\n                <li>Gupta AK, Talukder M, Shemer A. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia. <em>Expert Opin Pharmacother.<\/em> 2024 Feb;25(2):139-147. doi: 10.1080\/14656566.2024.2314087. Epub 2024 Feb 6. PMID: 38315101.<\/li>\r\n                <li>Seyed Jafari SM, Heidemeyer K, Hunger RE, de Viragh PA. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies. <em>J Clin Med.<\/em> 2024 May 23;13(11):3052. doi: 10.3390\/jcm13113052. PMID: 38892763; PMCID: PMC11172682. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38892763\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a> <\/li>\r\n                <li>Arif T, Dorjay K, Adil M, Sami M. Dutasteride in Androgenetic Alopecia: An Update. <em>Curr Clin Pharmacol.<\/em> 2017;12(1):31-35. doi: 10.2174\/1574884712666170310111125. PMID: 28294070. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28294070\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a><\/li>\r\n                <li>Motofei IG, Rowland DL, Baconi DL, et al. Androgenetic alopecia; drug safety and therapeutic strategies. <em>Expert Opin Drug Saf.<\/em> 2018 Apr;17(4):407-412. doi: 10.1080\/14740338.2018.1430765. PMID: 29363345. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29363345\/\" target=\"_blank\" rel=\"noopener\">Lien PubMed<\/a> <\/li>\r\n                <li>Varothai S, Shapiro MY. Edema and accelerated hair growth.   <em>J Am Acad Dermatol.<\/em>  2013;69(3):331-340.<\/li>\r\n            <\/ul>\r\n        <\/section>\r\n    <\/article>\r\n<\/div>\r\n\r\n<style>\r\n.medical-guide-page-wrapper {\r\n    background-color: #0A192F;\r\n    padding: 60px 20px;\r\n    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\r\n    color: #FFFFFF;\r\n    max-width: 1000px;\r\n    margin: 0 auto;\r\n}\r\n\r\n.guide-hero {\r\n    text-align: center;\r\n    margin-bottom: 40px;\r\n}\r\n\r\n.hero-title-wrapper {\r\n    display: flex;\r\n    align-items: center;\r\n    justify-content: center;\r\n    gap: 12px;\r\n    margin-bottom: 10px;\r\n}\r\n\r\n.hero-logo-box {\r\n    background: linear-gradient(135deg, rgba(17, 34, 64, 0.9), rgba(10, 25, 47, 0.95));\r\n    border: 1px solid rgba(212, 175, 55, 0.4);\r\n    border-radius: 8px;\r\n    padding: 4px 8px;\r\n    display: flex !important;\r\n    align-items: center !important;\r\n    justify-content: center !important;\r\n    width: 44px !important;\r\n    height: 44px !important;\r\n    box-shadow: 0 4px 15px rgba(0,0,0,0.3);\r\n    flex-shrink: 0;\r\n}\r\n\r\n.hero-inline-logo {\r\n    width: 32px !important;\r\n    height: 32px !important;\r\n    max-width: 32px !important;\r\n    max-height: 32px !important;\r\n    object-fit: contain !important;\r\n}\r\n\r\n.guide-subtitle {\r\n    color: #CBD5E1;\r\n    font-size: 15px;\r\n    margin: 0;\r\n}\r\n\r\n.medical-article-card {\r\n    background: linear-gradient(135deg, rgba(17, 34, 64, 0.85), rgba(10, 25, 47, 0.95));\r\n    border: 1px solid rgba(212, 175, 55, 0.3);\r\n    border-radius: 16px;\r\n    padding: 40px;\r\n    box-shadow: 0 10px 30px rgba(0,0,0,0.4);\r\n}\r\n\r\n.article-header {\r\n    border-bottom: 1px solid rgba(212, 175, 55, 0.2);\r\n    padding-bottom: 25px;\r\n    margin-bottom: 30px;\r\n}\r\n\r\n.article-category {\r\n    display: inline-block;\r\n    color: #D4AF37;\r\n    font-size: 10px;\r\n    font-weight: 700;\r\n    text-transform: uppercase;\r\n    letter-spacing: 2px;\r\n    background: rgba(212, 175, 55, 0.1);\r\n    padding: 4px 10px;\r\n    border-radius: 4px;\r\n    margin-bottom: 15px;\r\n}\r\n\r\n.medical-article-card h1 {\r\n    font-size: 28px;\r\n    color: #FFFFFF;\r\n    margin: 0 0 15px 0;\r\n    font-weight: 700;\r\n    line-height: 1.3;\r\n}\r\n\r\n.author-meta-box p {\r\n    font-size: 14px;\r\n    color: #CBD5E1;\r\n    margin: 3px 0;\r\n}\r\n\r\n.compilation-note {\r\n    color: #94A3B8;\r\n    font-size: 13px;\r\n}\r\n\r\n.medical-illustration-box {\r\n    margin: 30px 0;\r\n    text-align: center;\r\n    background: rgba(0, 0, 0, 0.2);\r\n    padding: 15px;\r\n    border-radius: 10px;\r\n    border: 1px solid rgba(255, 255, 255, 0.05);\r\n}\r\n\r\n.medical-illustration-box img {\r\n    max-width: 100%;\r\n    height: auto;\r\n    border-radius: 8px;\r\n    box-shadow: 0 4px 15px rgba(0,0,0,0.3);\r\n}\r\n\r\n.illustration-caption {\r\n    font-size: 13px;\r\n    color: #94A3B8;\r\n    margin-top: 10px;\r\n    font-style: italic;\r\n}\r\n\r\n.patient-info-box, .doctor-guide-box, .scientific-references-box {\r\n    margin-top: 35px;\r\n    background: rgba(10, 25, 47, 0.6);\r\n    border: 1px solid rgba(212, 175, 55, 0.2);\r\n    border-radius: 12px;\r\n    padding: 25px;\r\n}\r\n\r\n.medical-article-card h3 {\r\n    font-size: 18px;\r\n    color: #D4AF37;\r\n    margin-top: 0;\r\n    margin-bottom: 15px;\r\n    font-weight: 600;\r\n}\r\n\r\n.medical-article-card p, .medical-article-card li {\r\n    font-size: 14px;\r\n    color: #CBD5E1;\r\n    line-height: 1.6;\r\n}\r\n\r\n.styled-list {\r\n    padding-left: 20px;\r\n    margin: 10px 0;\r\n}\r\n\r\n.styled-list li {\r\n    margin-bottom: 10px;\r\n}\r\n\r\n.sub-list {\r\n    margin-top: 8px;\r\n    padding-left: 20px;\r\n    list-style-type: circle;\r\n}\r\n\r\n.scientific-references-box {\r\n    border-top: 1px solid rgba(212, 175, 55, 0.3);\r\n}\r\n\r\n.ref-list {\r\n    padding-left: 20px;\r\n    font-size: 13px;\r\n    color: #94A3B8;\r\n}\r\n\r\n.ref-list li {\r\n    margin-bottom: 12px;\r\n}\r\n\r\n.medical-article-card a {\r\n    color: #D4AF37;\r\n    text-decoration: underline;\r\n    transition: color 0.3s ease;\r\n}\r\n\r\n.medical-article-card a:hover {\r\n    color: #f3d06c;\r\n}\r\n\r\n\/* Mobil Uyumluluk *\/\r\n@media (max-width: 768px) {\r\n    .medical-article-card {\r\n        padding: 20px;\r\n    }\r\n    .medical-article-card h1 {\r\n        font-size: 22px;\r\n    }\r\n}\r\n<\/style>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Encyclop\u00e9die M\u00e9dicale Capillaire Pathologies dermatologiques et guides cliniques fond\u00e9s sur des preuves, selon les normes internationales. TRAITEMENTS CAPILLAIRES &#038; APPROCHE M\u00c9DICALE Traitements M\u00e9dicaux (Solutions Pharmacologiques et Topiques) \u2013 Guide de Gestion Clinique Pr\u00e9par\u00e9 par : Dr. Muhammet \u00d6zgehan | Association Turque des Maladies des Cheveux et du Cuir Chevelu Ce guide a \u00e9t\u00e9 compil\u00e9 par [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1195","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/pages\/1195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/comments?post=1195"}],"version-history":[{"count":0,"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/pages\/1195\/revisions"}],"wp:attachment":[{"href":"https:\/\/muhammetozgehan.com\/fr\/wp-json\/wp\/v2\/media?parent=1195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}